PH
Insider
Patrick J Heron
DirectorPatrick J Heron (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in MBX. Across 1 priced purchase filing, the average 21-session return was +10.0% from execution and +12.1% from disclosure (delay-adjusted; derived). The largest single filing was $9.0M of MIRM (131,425 sh × $68.48, as filed), executed Jan 23. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+10.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+12.1%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.0M
shares × price, as filed
Last traded
Jan 23
Filed Jan 27
Median ADV $83.1M across their filed names
Open performance→Volume by month
Buys $21.0M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
MBX
MBX
1 buy · 0 sells
1 filing
MIRMRecent filings
MIRMPURCHASE
Mirum Pharmaceuticals, Inc.
View filing →
$9.0M131,425 sh × $68.48
Exec Jan 23
Filed Jan 27 · 4:14 PM ET MBXPURCHASE MBX Biosciences, Inc. View filing → $12.0M
666,666 sh × $18.00
Exec Sep 26 2025
Filed Sep 30 2025 · 4:59 PM ET